LL-37 research peptide vial

Other research compounds

LL-37

Explore LL-37 research peptide online, third-party tested. Explore its antimicrobial and immunomodulatory mechanisms in host-defense research.

Catalogue record
OP-980
Intended use
Research use only
Independent COA on this site
Not available

This corporate catalogue does not take orders, display prices or provide dosage instructions.

Research record

Overview

Compound name: LL-37

Alternative names: Human cathelicidin antimicrobial peptide; CAMP

Compound classification: Endogenous antimicrobial peptide

Brief factual description:

LL-37 is the only cathelicidin-derived antimicrobial peptide expressed in humans. It plays a critical role in innate immunity by directly disrupting microbial membranes and modulating immune responses, inflammation, and tissue repair.

Mechanism of Action

Primary biological targets:

Microbial membranes; immune signaling pathways

Affected systems: Immune, integumentary, inflammatory

Receptor selectivity:

Not strictly receptor-dependent; interacts with membranes and multiple immune receptors

Downstream signaling effects:

Disruption of bacterial, viral, and fungal membranes

Chemotactic signaling for immune cells

Modulation of cytokine and inflammatory responses

Frequently asked questions

What this record can—and cannot—confirm

Is LL-37 approved for human use?

LL-37 is supplied strictly for in-vitro laboratory and research use only, not for human consumption or therapeutic use. Regulatory treatment varies by jurisdiction.

How is the purity of LL-37 verified?

No independent report for this specific product was available in the public migration source. Request batch-specific documentation from the authorised reseller before relying on a purity claim.

Where can I buy LL-37?

Through an OnlinePeptides authorized reseller. Verify any reseller at onlinepeptides.com/verify-reseller/ before purchasing.